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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYWe show here that singular loss of the Bright/Arid3A transcription factor leads to reprograming of mouse embryonic fibroblasts (MEFs)
and enhancement of standard four-factor (4F) reprogramming. Bright-deficient MEFs bypass senescence and, under standard embryonic
stem cell (ESC) culture conditions, spontaneously form clones that in vitro express pluripotency markers, differentiate to all germ line-
ages, and in vivo form teratomas and chimeric mice. We demonstrate that BRIGHT binds directly to the promoter/enhancer regions of
Oct4, Sox2, and Nanog to contribute to their repression in both MEFs and ESCs. Thus, elimination of the BRIGHT barrier may provide an
approach for somatic cell reprogramming.INTRODUCTION
Cellular reprogramming from a differentiated state to a
pluripotent state is an important tool for studying early
development, modeling disease states, and investigating
regulatory mechanisms underlying pluripotency. Enforced
expressionof combinationsof corepluripotency-related fac-
tors in somatic cells can generate induced pluripotent stem
cells (iPSCs) from a range of cell types (Anokye-Danso
et al., 2011; Takahashi and Yamanaka, 2006). While iPSCs
hold great promise for regenerativemedicine, their efficient
production is inhibited by several pathways, including
lineage-specific transcription factors (Ichida et al., 2009; Li
et al., 2009) and targets of the mir-34 and Let-7 family of
microRNAs (Choi et al., 2011; Melton et al., 2010).
Conversely, loss of p53/p21 (Kawamura et al., 2009) or over-
expression of hTERT (Mathew et al., 2010) or SV40Tantigen
(Yu et al., 2009) can increase conventional reprogramming,
largely through bypass of cellular senescence.
Bright/Arid3A is the foundingmember of the ARID family
of transcriptions factors (Herrscher et al., 1995; Wilsker
et al., 2002) and is required for hematopoietic stem cell
differentiation and B cell development (Webb et al.,
2011). Several somatic cell types from rare survivors of con-
ventionalBright knockout (KO)micewere developmentally
plastic, with the capacity to differentiate into multiple lin-
eages (An et al., 2010). This plasticity was accompanied by
enhanced expression of SOX2 and NANOG; however, the
clones did not fulfill in vivo requirements for pluripotency.26 Stem Cell Reports j Vol. 2 j 26–35 j January 14, 2014 j ª2014 The AuthorThese results prompted the hypothesis that Bright defi-
ciency may stimulate somatic cell reprogramming. Here,
we show that Bright transcription-factor-deficient mouse
embryonic fibroblasts (MEFs) are enhanced for standard
four-factor (4F) reprogramming and are capable of sponta-
neously forming stable embryonic stem-like cells. We
demonstrate that BRIGHT binds directly to the promoter/
enhancer regions of Oct4, Sox2, and Nanog to contribute to
their repression in somatic and embryonic stemcells (ESCs).RESULTS
To address the potential mechanism underlying the plas-
ticity of Bright-deficient somatic cells, we compared MEFs
derived from Bright KO embryos (KO-MEFs) to sibling
wild-type MEFs (WT-MEFs). KO-MEFs were morphologi-
cally similar to WT-MEFs but grew at a slower rate (Fig-
ure 1A). Further, they bypassed senescence (Figure 1B)
and retained the capacity for self-renewal for more than
24 weeks (data not shown)—properties associated with
stem cells. Global gene expression analyses indicated that
KO- and WT-MEFs did not differ among gene signatures
associated with ESC identity, including ESC core, c-MYC,
PRC, and bivalently marked promoters (H3K4m3 and
H3K27m3) (Bernstein et al., 2006; Kim et al., 2010) (Fig-
ure S1A available online). However, Gene Ontology
analyses of global microarray data demonstrated that KO-
MEFs had activated some pathways suggestive of a mores
(legend on next page)
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KO-MEFs might have overcome some of the hurdles to
reprogramming.
To test their potential to reprogram, WT- and KO-MEFs
were transfected with standard 4F (Oct4, Sox2, Klf4, and
c-Myc) lentiviral constructs. KO-MEFs (KO+4F) reprog-
rammed colonies developed 7–10 days earlier and more
efficiently (15- to 40-fold) than WT-MEFs (WT+4F) in five
independent experiments (Table S1). KO+4F gave rise to
stable iPSC-like clones as defined by their ability to
undergomore than four passages, to form embryoid bodies
(EBs) that differentiate into all germline lineages, and to
express pluripotency markers at similar levels to those
observed inWT+4F clones (Table S1; Figure 1C; Figure S1C).
Unlike WT-MEFs, KO-MEFs were able to bypass the
requirement for Sox2 (KO-S) and Klf4 (KO-K), although
they produced fewer stable clones than KO+4F clones
(Table S1; Figure 1C). Consistent with the observations
of KO-MEFs, reducing BRIGHT levels in WT-MEFs ectopi-
cally by small hairpin RNA (shRNA) knockdown (KD)
followed by 4F lentiviral-mediated transfection (KD+4F)
enhanced iPSC colony formation above that of WT+4F
(Figures S1D–S1G).
We observed that KO-MEFs alone spontaneously formed
alkaline phosphatase (AP)-positive colonies within 2 weeks
in standard MEF culture conditions (Figure 1D). Upon
culture in iPSC/mouse ESC (mESC) culture conditions,
KO-MEFs underwent spontaneous reprogramming and
formed stable clones within 4 weeks (KO-iPS; Table S1;
Figures 1C and S1H). Comparisons of pluripotency marker
expression (Figure 1C), in vitro differentiation capability
(Figure S1C), and teratoma formation (Figure 1E; Table
S2) suggested that not only the KO+4F and KO-S clones
but also the KO-iPS were pluripotent. The parental KO-
MEFs were unable to form either EBs via hanging drop
culture or teratomas (Table S2; data not shown). Indepen-Figure 1. Bright/ Mouse Embryonic Fibroblasts Bypass Senesce
(A) Growth curves of KO-MEFs and WT-MEFs; n = 4 biological replicate
(p% 0.1), as determined by Student’s t test.
(B) Senescence of WT-MEFs and KO-MEFs following <15 (WT-MEFs)
b-galactosidase (blue) staining; images 203; insets of unstained cel
(C) Immunocytochemistry (ICC) of conventional mESC markers of four-
MEFs without Sox2 (KO-S), and spontaneous KO-MEF colonies (KO-iPS
DAPI and ICC overlays of OCT4 and SSEA demonstrate appropriate loc
(D) KO-MEFs form spontaneous alkaline phosphatase (AP)-positive co
image with AP, red; DAPI, blue. Below: bright-field, images at 103.
(E) WT+4F, KO+4F, and KO-iPS form teratomas. The three germ layers
(F) KO-iPS form chimeric mice. Independent Bright/ reprogramm
embryonic day 3.5 (E3.5) C57BL/6-cBrd/cBrd/Cr blastocysts. Uppe
construct-associated b-galactoside activity by LacZ staining of wh
identified in tail preparations by the production of a 408 bp PCR pro
Gapdh (lower lanes) served as a loading control.
See also Figure S1 and Tables S1 and S2.
28 Stem Cell Reports j Vol. 2 j 26–35 j January 14, 2014 j ª2014 The Authordently derived KO-iPS lines displayed normal karyotypes
(data not shown) and were capable of contributing to the
formation of germ lineages when introduced into preim-
plantation albino host embryos, as detected by expression
of the b-galactosidase-marked Bright disrupted loci in
embryonic day 18.5 (E18.5) retinas and by direct PCR
detection of the disrupted locus in corresponding tail
DNAs (Figure 1F). Thus, Bright KO-iPS are capable of
contributing to chimeras in vivo, giving rise to retinal ecto-
derm and tail mesoderm.
Quantitative PCR (qPCR) arrays indicated that the
absolute gene expression levels of pluripotency and differ-
entiation-related genes of multiple, independent clones
derived from KO-MEFs, either by standard reprogramming
(KO+4F, KO-S) or spontaneous formation (KO-iPS),
closely resemble mESC and WT+4F expression patterns
(Figures 2A–2C, S2, and S3A–S3C). Consistent with this,
CpG sites localized within 175 bp 50 to the transcription
start site (TSS) of Oct4 were completely demethylated in
KO-iPS clones compared to both WT and KO-MEFs
(Figure 2D). Global gene expression analysis confirmed
that KO-iPS and mESCs were comparable with respect to
upregulation of other conventional pluripotency genes
(Figure 2E; Figures S3B and S3C) as well as expression of
markers of early differentiation (Figure S3D). Global ana-
lyses further indicated that, of the few genes that have
been previously observed to be differentially expressed
between mESCs and epiblast stem cells (EpiSC) (De Miguel
et al., 2010), KO-iPS have an intermediate gene expression
pattern (Figure S3E). EpiSC are pluripotent cells, highly
similar to mESCs, that are derived from the postimplanta-
tion epiblast and thus represent a later developmental stage
(De Miguel et al., 2010).
The above results led us to the hypothesis that BRIGHT
may function as a transcriptional repressor of key plu-
ripotency genes. Chromatin immunoprecipitation qPCRnce and Undergo Spontaneous Reprogramming
s; error bars show the SD. Asterisks denote statistical significance
and >50 (KO-MEFs) population doublings as measured by acidic
ls 103.
factor (4F) reprogrammed WT-MEFs (WT+4F), KO-MEFs (KO+4F), KO-
). Insets are corresponding nuclear DAPI stains. Enlarged images of
alization.
lonies under standard fibroblast culture conditions. Above: merged
are indicated.
ed C57BL/6 iPSC lines (KO-iPS1 and KO-iPS2) were injected into
r: chimerism within E18.5 retina detected via expression of KO
ole-mount embryos. Lower: transfer of the Bright null allele was
duct with Bright-specific and NeoR cassette primers (upper lanes);
s
(legend on next page)
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was recruited to the proximal promoter regions of Oct4,
Sox2, and Nanog (Figure 3A). ChIP sequencing (ChIP-seq)
confirmed these sites and identified additional BRIGHT
binding within extended promoter regions (5 kb ± to
respective TSSs; Figure 3B). We next probed subregions
within the proximal promoters for BRIGHT binding by
electrophoretic shift assay (EMSA). Within the Oct4
promoter, BRIGHT bound to both the proximal enhancer
(PE) and to a region directly downstream (Bb) that contains
several BRIGHT consensus motifs (Figures 3C and 3D) but
to neither the distal enhancer (DE) nor the minimal
promoter (MP; data not shown). The PE has been suggested
to act as a target for Oct4 repression (Yeom et al., 1996).
BRIGHT bound within the Sox2 promoter to the R1
enhancer (Figure 3E), a previously identified transactiva-
tion motif in cancer stem cells (Leis et al., 2012). BRIGHT
bound within the Nanog promoter to an A/T-rich region
350 bp upstream of the start site (Figure 3F) that was
shown as the site of OCT4/SOX2 binding (Kuroda et al.,
2005). These data indicate that BRIGHT is capable of
binding cis-acting regions previously shown to be key to
core factor gene regulation.
BRIGHT was previously identified by mass spectrometry
(MS) as a secondary binding partner of enforced expression
of NANOG in mESCs (Wang et al., 2006), but no follow-up
analysis was performed. Employing coimmunoprecipita-
tion in mESCs, we confirmed endogenous interactions of
BRIGHT with NANOG as well as with OCT4 and SOX2
(Figure 4A). These data, along with our inability to detect
any of these interactions when each was overexpressed
pairwise in somatic cells (data not shown), prompted a
parallel examination of BRIGHT function in mESCs.
BRIGHT transcript expression increased significantly
following in vitro differentiation, an inverse correlation
with core factor expression (Figure 4B). Differentiation
led to increased BRIGHT protein accumulation within theFigure 2. Mouse Embryonic Stem Cells and Reprogramed KO-MEF
(A) qPCR array comparison of mESC expression to 4F reprogrammed K
spontaneous KO-MEF colonies (KO-iPS) expression. Absolute values are
(shown in Figure S2) as fold-change relative to WT-MEFs (please see Su
SD.
(B) Heatmap of selected pluripotency factors (from full data set of Fi
(C) Scatterplot comparisons of qPCR array data are shown for (I) KO-iPS
and (IV) KO+4F versus WT+4F. Diagonal lines show the zero axis and 2-f
change in normalized gene expression (log 10); red circles, overexpr
replicate values for each gene was used to calculate p values; stati
Figure S3A.
(D) Bisulfite sequencing of 175 bp 50 of the transcriptional start sit
methylated CpG positions; open circles represent unmethylated CpG p
(E) Representative heatmap of selected pluripotency factor expression
to their expression in WT-MEFs.
See also Figures S2 and S3.
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most active site of BRIGHT transcriptional activity (Zong
et al., 2000). In mESCs, stable overexpression of BRIGHT
at levels below those required to initiate differentiation
(Figure S5A) led to its recruitment to Oct4, Sox2, and Nanog
promoters (Figure 4D). Thus, reciprocal to what is observed
for loss of BRIGHT in somatic cells, we reasoned that an
increase in levels of BRIGHT, in association with ESC-
specific interacting proteins, might repress core pluripo-
tency factor transcription. Accordingly, the endogenous
loci ofOct4, Sox2, andNanogwere downregulated following
overexpression of BRIGHT in undifferentiated mESCs and
in themouse embryonic carcinoma cell line p19 (Figure 4E;
Figure S4B). Employing luciferase reporters that contained
the promoter/enhancer regions shown in Figure 3B, we
observed strong repression following transient BRIGHT
overexpression, regardless of the mESC differentiation
state (Figure 4F; Figure S4C). These data indicate that
BRIGHT directly represses transcription of core pluripo-
tency factors and suggest a role for BRIGHT as an activator
of differentiation.DISCUSSION
We have demonstrated that complete loss of Bright expres-
sion in MEFs is alone sufficient for both induction of
somatic cell reprogramming and for increased efficiency
of conventional iPSC reprogramming. We suggest that at
least three separate steps contribute to the mechanism by
which Bright loss facilitates reprogramming.
First, Bright KO-MEFs are refractory to cellular senes-
cence, promoting somatic self-renewal (Figure 1B). Telo-
mere shortening and activation of Rb or p53 are key
senescence-inducing factors (Zhao and Daley, 2008).
Neither cell cycle nor signature transcripts of these families
were significantly altered in KO-MEFs (data not shown).Lines Have Comparable Gene Expression Profiles
O-MEFs (KO+4F), KO-MEFs reprogrammed without Sox2 (KO-S), and
calculated from the average values of multiple, independent clones
pplemental Experimental Procedures for details); error bars show the
gure S2) showing average magnitudes of multiple clones.
versus mESCs, (II) WT+4F versus KO-iPS, (III) KO+4F versus KO-iPS,
old differences in expression. Each circle represents the average fold
essed; green circles, underexpressed genes. Student’s t test of the
stically different genes among each category pair are detailed in
e (TSS) of Oct4 in the indicated cell types. Filled circles represent
ositions.
levels from global array analyses of mESCs and KO-iPS, as compared
s
(legend on next page)
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p53 (Lestari et al., 2012), a previously established barrier
to reprogramming (Li et al., 2009), suggests that Bright
loss bypasses senescence through a mechanism other
than transcriptional derepression of pluripotency factors,
alleviating the requirement for derepression as the initi-
ating step to reprogramming. Unlike loss or mutation of
p53, Bright KO-MEFs do not undergo genomic instability
at a level detectable by karyotype (data not shown).
Second, loss of Bright leads to direct derepression of
key regulators of pluripotency. This conclusion is sup-
ported by our observations that (1) BRIGHT upregulation
and nuclear matrix localization (Figures 4B and 4C)
accompany mESC differentiation and the well-established
downregulation of OCT4, SOX2, and NANOG in mESCs
(De Miguel et al., 2010), (2) BRIGHT is recruited to pro-
moter/enhancer regions of these factors in MEFs and
mESCs (Figures 3A and 4D), and (3) BRIGHT overexpres-
sion inmESCs represses both endogenous loci and reporter
transcription of Oct4, Sox2, and Nanog (Figures 4E and 4F).
Loss of BRIGHT repression, in conjunction with activation
of the leukemia-inhibitory factor (LIF) signaling pathway,
may be key to BRIGHT-mediated reprogramming.
Third, loss of Bright in MEFs might disrupt signaling
pathways shown to antagonize pluripotency through
core factor repression. One such pathway, Activin/TGF-b,
is upstream of BRIGHT in human lung (Lin et al., 2008)
and in Xenopus gastrulation, where BRIGHT is required
for mesoderm differentiation (Callery et al., 2005). Likely
additional, as-yet-uncharacterized signal pathways are
altered by loss of Bright following transfer of KO-MEFs to
LIF-augmented cultures. These data further suggest that a
normal function of BRIGHT is to promote and maintain
cell differentiation.
Why ectopic BRIGHT knockdown was capable of stimu-
lating reprogramming by the conventional 4F method but
not singularly is unclear. While BRIGHT levels in MEFs are
modest compared to hematopoietic tissues (Webb et al.,
2011), we were only able to achieve 75% reduction in
transcript levels (Figure S1E). It is probable that the residualFigure 3. Bright Is Recruited to Promoter/Enhancer Regions of K
(A) Anti-BRIGHT ChIP-qPCR of WT-MEF chromatin, with primer pairs d
(B) Upper panels: schematics of the 50 promoter regions of Oct4 (top),
(Chew et al., 2005; Rodda et al., 2005; Tomioka et al., 2002); stars,
binding; arrows, ChIP primers; blue horizontal lines, EMSA probes; DE,
promoter regions, described in (C) and Figure 4F. Lower panels: in vivo
downstream of corresponding TSSs), as determined by ChIP-seq in WT
were scaled to the schematics, and dotted lines indicate BRIGHT ChI
(C–F) Confirmation of direct BRIGHT binding in vitro by EMSA. (C) Reco
Bb region of Oct4; (E) to the R1 region of Sox2; and (F) to the proxima
antibody; preimmune, sera collected prior to immunization; IVT BRIGH
binding motif from an immunoglobulin variable region promoter (Ni
arrows denotes free probe.
32 Stem Cell Reports j Vol. 2 j 26–35 j January 14, 2014 j ª2014 The AuthorBRIGHT remaining under our best-optimized conditions
was sufficient to prevent minimally required pluripotency
gene derepression. We are currently employing CRISPR
technology in an effort to achieve absolute ectopic elimina-
tion and to determine if the difference is a trivial issue of
dosage or an inherited state of Bright-deficient mesen-
chymal progenitors.
We show here that loss of Bright increases standard
reprogramming and can spontaneously lead to robust
dedifferentiation to a pluripotent state. Bright functions,
in part, through direct repression of key pluripotency
factors, implicating Bright as a potentially key regulatory
factor during cell-fate decisions and maintenance of a
differentiated state. The potential for translating BRIGHT
reduction/loss of function into a medically relevant tech-
nology faces additional hurdles. While Bright KO-iPS
readily form teratomas in vitro and contribute to chimeras
in vivo (Figures 1E and 1F), we have yet to achieve germline
transmission from the chimeric mice. This may result from
the relatively low levels of chimerism and/or from the
restricted lineage contribution (Figure 1F). A potential
contributor to low chimerism efficiency is the intermediate
EpiSC gene expression pattern of KO-iPS (Figures S2F and
S3E).While ESCs form chimeras in preimplantation blasto-
cysts, EpiSCs efficiently contribute to chimeras only in
postimplantation embryos (Huang et al., 2012), indicating
that both pluripotent cell types require specific develop-
mental conditions in order to properly differentiate.EXPERIMENTAL PROCEDURES
Mice were used with institutional approval and within review
board-specified guidelines. Details of all experiments are provided
in Supplemental Experimental Procedures. ESCs and iPSCs were
grown on STO or WT-MEF feeder cells mitotically inactivated
with mitomycin C with or without 10 ng/ml LIF. Cellular
senescence was determined in subconfluent cultures by acidic
b-galactosidase activity. Reprogrammingwas performedwith tetra-
cycline-inducible vectors as previously described (Takahashi and
Yamanaka, 2006). Chimeras were constructed and analyzed asey Pluripotency Transcription Factors
enoted in (B). n = 3 biological replicates. Error bars show the SD.
Sox2 (middle) and Nanog (bottom). Ovals, OCT4/SOX2binding sites
BRIGHT consensus binding motifs; semicircles, confirmed BRIGHT
PE, Bb, MP, R1, Core, PP denote specific binding areas of indicated
BRIGHT binding within the Oct4, Sox2, and Nanog loci (5 kb up- or
-MEFs in two independent experiments (Bri1 and Bri2). These data
P-seq peaks confirmed by EMSA.
mbinant BRIGHT binds to the proximal enhancer (PE) and to (D) the
l promoter (PP) region of Nanog. aBRIGHT, anti-BRIGHT polyclonal
T, recombinant BRIGHT protein; IgVH, an established BRIGHT DNA
xon et al., 2004). Black arrows denote specific complexes; empty
s
Figure 4. Bright Interacts with and
Represses Transcription of Key Pluripo-
tency Factors in mESCs
(A) Anti-BRIGHT coimmunoprecipitation
in mESCs. Input, whole-cell lysate; aIg,
preimmune serum; aBRIGHT, anti-BRIGHT
polyclonal antibody.
(B) qPCR analysis of Bright endogenous
expression in mESCs at the indicated days
following removal from feeder cells and LIF
in differentiating, adherent cultures. NTC,
no template control. n = 3 biological repli-
cates. Error bars show the SD.
(C) BRIGHT accumulates preferentially
within mESC nuclear matrix during differ-
entiation as shown by four-way fraction-
ation/western blot analysis. Loading of
equivalent protein in each fraction was
confirmed (data not shown). CY, cytoplasm;
NP, soluble nuclear; CH, chromatin; NM,
nuclear matrix fractions.
(D) Anti-BRIGHT ChIP-qPCR of mESC chro-
matin following stable BRIGHT over-
expression; primer pairs are denoted in
Figure 3B. n = 3 biological replicates. Error
bars show the SD.
(E) qPCR analysis of endogenous Oct4,
Sox2, and Nanog transcripts in mESCs
stably overexpressing BRIGHT relative
to empty-vector control mESCs. n = 3
biological replicates. Error bars show
the SD.
(F) Transient BRIGHT overexpression re-
presses Oct4 (left), Nanog (below), and
Sox2-R1 (right) promoter/enhancer-
driven reporter expression. Luciferase
reporters maintained the endogenous
TSSs (Figure 3B, right angle arrows) for
Oct4 and Nanog or the indicated section
of the promoter (Figure 3B, open box)
for Sox2. Three biological replicates
performed with three technical replicates per experiment in which vector-only values were set to 1. Error bars show the SD. Asterisks
denote statistical significance (p% 0.1), as determined by Student’s t test.
See also Figure S4.
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Bright/Arid3A Regulates Somatic Cell Reprogrammingdescribed elsewhere (Webb et al., 2011) through injection of
KO-iPS into cBrd/cBrd blastocysts with germline transmission
confirmed by b-galactosidase staining and tail-clip PCR. Global
microarray analyses employed Nimblegen chips and were
analyzed using Java Treeview and DAVID. Chromatin immuno-
precipitation, EMSA, and subcellular fractionation were employed
as described previously (Fujita and Wade, 2004; An et al., 2010;
Zong et al., 2000).
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